Read More 2 minute read Pharma Industry News Dupixent receives FDA approval for treatment of moderate-to-severe asthma Sanofi and Regeneron Pharmaceuticals’ Dupixent (dupilumab) has achieved a significant milestone with the U.S. Food and Drug Administration… bypharmanewsdailyOctober 21, 2018
